Whether it’s costs, safety risks, or pill fatigue they’re trying to reduce, many health systems and clinics have started working on ways to encourage deprescribing of medications that patients may not need. A new study discusses the potential promise and pitfalls of a massive effort to reduce overuse of a common class of heartburn medications known as proton pump inhibitors or PPIs.
